ERBB2 and breast carcinoma: In clinical practice, Oncotype Dx and MammaPrint are the most frequently used first-generation multi-gene assays, and EndoPredict and Prosigna are the most used second-generation multi-gene assays for ER+/HER2- breast cancer (4).